Intraoperative and early postoperative flap-related complications of laser in situ keratomileusis using two types of Moria microkeratomes

Prediction model of free flaps in microkeratome-assisted LASIK

Purpose

To identify mechanical factors, as well as patients’ biometric and surgeons’ experience factors that correlate with the FF incidence in microkeratome (MK)-assisted LASIK and to construct a predictive model based on these parameters.

Methods

55,700 consecutive LASIK treatments of 28,506 patients between January 2017 and April 2020 done by 50 surgeons in 10 centers, all with Sub Bowman Keratome (SBK) and 90μ head (OUP) were analyzed retrospectively for the incidence of FF and their correlation to mean keratometry, central corneal thickness, MK ring height and stop, as well as surgeons’ experience. A prediction model was built and tested for sensitivity and specificity.

Results

The incidence of FF using the SBK MK was 0.276%. Risk factors were low central corneal thickness, very flat (-1) or very thick (+2) ring height, and higher stop values (p<0.001). Mean keratometry and low surgeon experience were not correlated to FF incidence. A prediction model with a cut-off FF risk of 0.274%, a 76% specificity, and a 73% sensitivity was applied.

Conclusions

Free flaps are rarely seen in modern MK LASIK. However, the incidence of this complication using the SBK MK increases using higher stop values, very thick and very thin MK rings, and in eyes with thin corneas.

Disruption of ingrown epithelium via Nd:YAG laser or DIEYAG. A retrospective case series of Post-LASIK patients

Purpose

To describe in detail the technique used and results of disruption of ingrown epithelium via Nd:YAG laser (DIEYAG) after LASIK treatment and enhancement.

Observations

Epithelial ingrowth following laser in situ keratomileusis (LASIK) enhancement has the potential to cause significant refractive error and discomfort when allowed to progress. This retrospective case series following seven eyes after LASIK enhancement and one eye with flap trauma, assessed the effectiveness and safety of the disruption of ingrown epithelium via Nd:YAG laser. In all cases, we found that the progression of ingrown epithelium was eliminated. Using best spectacle corrected visual acuity and topography as our main outcome measures, we found that refractive error and visual disturbance caused by ingrowth stabilized or improved, with no subsequent complications identified.

Conclusion and Importance

The disruption of ingrown epithelium via Nd:YAG laser offers a safe and effective alternative to other treatments for epithelial ingrowth after LASIK treatment and enhancement.

Non adherence of flap following microkeratome-assisted laser-assisted in situ keratomileusis: A case report and review of literature

A 28-year-old male underwent microkeratome assisted Laser-assisted in situ keratomileusis (LASIK) for, myopia. On postoperative day 1, patient had a large epithelial defect in OD. The corneal epithelial defect healed within 72 hours, but sub-optimal vision persisted. The patient was referred for further management to us. On evaluation, patient had non-healing of flap margin at 5 o'clock. Fluoroscein stain revealed no corneal epithelial defect, but a large pool of dye beneath the LASIK flap. A clinical diagnosis of non-adherence of LASIK flap was considered. Application of bandage contact lens was done. LASIK flap completely healed in 1 week. Possible etiologies are discussed and literature is reviewed.

Short-term complications of femtosecond laser-assisted laser in situ keratomileusis cuts: Review of 1210 consecutive cases

PURPOSE

To evaluate short-term complications after femtosecond laser cuts for laser in situ keratomileusis (LASIK).

SETTING

Department of Ophthalmology, Goethe University, Frankfurt, Germany.

DESIGN

Retrospective consecutive case series.

METHODS

Consecutive femtosecond laser cuts (1210 cuts in 624 patients) from LASIK performed with the Intralase FS60 between 2006 and 2014 were analyzed. The analysis looked at intraoperative and postoperative complications at 1 day, 1 week, and 1 month and factors with potential impact on the complication rate, such as ablation depth.

RESULTS

No irregular, incomplete, or thin flaps, buttonholes, gas breakthrough, or free caps were observed. Intraoperatively, incomplete side cuts were observed in 4 cases (0.3%). Three of the 4 occurred during the first year of femtosecond laser usage and were explained by a software problem. Epithelial defects, limbal bleeding, and decentered flaps without negative impact on outcome were observed in 45 (3.7%), 12 (1.0%), and 5 (0.4%) eyes, respectively, on the treatment date. Diffuse lamellar keratitis (DLK) stage 1 was observed in 69 (5.7%), 36 (3.0%), and 3 (0.2%) eyes at 1 day, 1 week, and 1 month, respectively, and DLK stage 2 in 20 (1.7%), 6 (0.5%), and 2 (0.2%) eyes, respectively. An increase in total ablation depth resulted in a higher incidence of microstriae (P < .01 at 1 day, 1 week, and 1 month). An increase in the optical zone resulted in a significantly higher incidence of epithelial ingrowth at 1 day and 1 week (P < .01).

CONCLUSION

No major cut-related complications were observed. The femtosecond laser is a safe option to create a flap in LASIK.

FINANCIAL DISCLOSURE

Proprietary or commercial disclosures are listed after the references.

Incidence, Indications, and Outcomes of Eyes Needing Early Flap Lifting After LASIK

PURPOSE

To analyze the incidence, indications, and outcomes associated with early flap relifting after uncomplicated laser in situ keratomileusis (LASIK).

METHODS

All LASIK cases from a single surgical center between 2007 and 2015 were reviewed. Early postoperative flap lift cases (<15 d after surgery) were identified.

RESULTS

Overall, 25,712 eyes were included, of which 366 (1.42%) underwent early postoperative flap lifting. There was a significant reduction in early postoperative flap lifting rates from 2006 (2.46%) to 2015 (0.92%) (P = 0.001). Reasons for early flap lifting included striae (n = 301, 1.17%), diffuse lamellar keratitis (n = 62, 0.24%), flap dislocation (n = 20, 0.08%), epithelial ingrowth (n = 18, 0.07%), and interface debris (n = 15, 0.06%). There was a significant difference in rates and outcomes of flap relifting among high-volume surgeons (P < 0.001). The flap lift group had a significantly lower final safety index (0.95 ± 0.16 vs. 1.01 ± 0.15, P < 0.001), efficacy index (0.85 ± 0.26 vs. 0.94 ± 0.26, P < 0.001), and a higher distance from target refraction (0.39 ± 0.61 vs. 0.21 ± 0.46 D). In unilateral cases, the study eye had a lower safety index (P < 0.001), efficacy index (P < 0.001), and greater distance from target refraction (P = 0.003) compared with the fellow eye. After intervention, 81.1% of cases achieved full resolution, 10.1% achieved partial resolution, 4.1% required additional flap relifting, and 4.7% were nonresolved by the end of follow-up.

CONCLUSIONS

The main indication for early flap relifting after LASIK was striae, and most cases achieved full resolution. Although refractive and visual outcomes are lower in this group, they are, nevertheless, satisfactory.

Visumax femtolasik versus Moria M2 microkeratome in mild to moderate myopia: efficacy, safety, predictability, aberrometric changes and flap thickness predictability

Introduction

This is an interventional prospective clinical study which was conducted to evaluate the efficacy, safety, predictability, ocular aberrations, and flap thickness predictability of Visumax femtosecond laser (FSL) compared to Moria M2 microkeratome (MK) in mild to moderate myopia.

Methods

This study included 60 eyes who were divided into two groups. Thirty eyes in group (I) in which the flap was created with Visumax FSL, while in group II (30 eyes) the Moria M2 MK was used. Keratometric, refractive, and aberrometric measurements were compared preoperatively and 3 months postoperatively. The intraoperative subtraction pachymetry (the SP 100 Handy pachymeter (Tomey, Nagoya, Japan) was used for preoperative pachymetry and flap thickness measurement.

Results

No significant difference was found between the two groups in regards to postoperative manifest sphere, spherical equivalent, astigmatism, safety indices nor ocular aberrations. Twenty six eyes (86.6%) in group I and 23 eyes in group II (76.6%) were within ±0.5D of the intended correction and 23 eyes (76.6%) in group I and 15 eyes in group II (50%) were within ±0.25D of the intended correction. In group I, the mean postoperative actual flap thickness was 100.12 ± 16.1 μm (81 to 122 μm), while in group II, it was 104.6 ± 20.1 μm (62 to 155 μm). The difference was statistically significant (p = 0.001).

Conclusions

Both Visumax and Moria M2 MK are safe and effective in treating myopia with no statistically significant difference in induction of ocular aberrations but with potential advantage for Visumax regarding predictability. More accurate flap thickness is achieved with Visumax femtolasik.

Trial registration

This study was retrospectively registered on 19/6/2017. Trial registration number NCT03193411, clinicalTrials.gov.